SCHEMBL435291

SCHEMBL435291

C[C@@H](c1nncc2cc(-c3cccc(C(N)=O)c3)ccc12)C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.43
CCNE2 O96020 1/20 0.43
CCNE1 P24864 1/20 0.43
ERN1 O75460 3/20 0.42
CCNT1 O60563 1/20 0.41
CCND1 P24385 1/20 0.41
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CDK7 P50613 1/20 0.41
CDK9 P50750 1/20 0.41
CCNH P51946 1/20 0.41
MNAT1 P51948 1/20 0.41
CDK6 Q00534 1/20 0.41
PDK2 Q15119 1/20 0.39
MAP3K5 Q99683 1/20 0.39
SYK P43405 2/20 0.39
LIMK1 P53667 3/20 0.38
LDHB P07195 1/20 0.38
ADAMTS4 O75173 1/20 0.38
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL437501 1.00 CDK2 (0.43) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL3955501 0.82 MAPK14 (0.54) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL397514 0.82 ALOX5AP (0.45) PDK2MAPK14TRPV1CHEK1LCK
SCHEMBL435776 0.78 CDK2 (0.45) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL439662 0.78 CDK2 (0.45) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL436516 0.78 CDK2 (0.45) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL436517 0.75 PDK2 (0.43) CDK2CCNE2CCNE1ERN1CCNT1
SCHEMBL396560 0.74 MAPK14 (0.55) MAP3K5LDHBMAPK14MAPK13ABL1
SCHEMBL397201 0.74 NPC1 (0.45) KDR
SCHEMBL395778 0.72 MAPK14 (0.55) MAPK14ABL1LCKLYNKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101612-B2 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes AMGEN INC. (US) 2012-01-24 US disclosed